---
title: Nuvisan vs PI Health Sciences
slug_a: nuvisan
slug_b: pihealthsciences
site: cro
review_signal_gate: closed
canonical_path: /compare/nuvisan/pihealthsciences
---

# Nuvisan vs PI Health Sciences

Side-by-side profile data from each company listing on this directory.

## Nuvisan

- Profile: [/companies/nuvisan](/companies/nuvisan)

Nuvisan — Full-service CRO and CDMO with specialized competency centers in drug discovery, formulation development, GMP manufacturing, and bioanalytical services across Germany and France.

Services: 32. Modalities: 2. Indications: 2. Locations: 8. Certifications: 0. The strongest documented coverage currently appears in services (32).

### Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- Protein Engineering
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- In Vivo PK / PD Studies
- Bioanalysis
- Biomarker Assays
- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Regulatory Affairs
- Analytical Method Development & Validation
- ICH Stability Studies
- Translational Research
- Oncology Specialty Services
- Genomics & Sequencing Services
- Bioinformatics & Data Science
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Biologics (Other)

### Indications

- Oncology
- Dermatology

### Phases

- Discovery
- Preclinical (General)
- Phase I
- Phase II

### Sourcing models

- Full-Service Outsourcing (FSO)

## PI Health Sciences

- Profile: [/companies/pihealthsciences](/companies/pihealthsciences)

PI Health Sciences — PI Health Sciences is an integrated CRDMO offering end-to-end drug discovery, development, and manufacturing services with R&D and manufacturing locations in Europe and India.

Services: 28. Modalities: 1. Indications: 0. Locations: 10. Certifications: 0. The strongest documented coverage currently appears in services (28).

### Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- Genetic Toxicology
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- GLP Toxicology
- Regulatory Affairs
- Analytical Method Development & Validation
- ICH Stability Studies
- Translational Research
- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Flow Chemistry & Continuous Manufacturing
- Solid-State Chemistry & Polymorph Screening
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Small Molecule

### Indications

- Data not yet provided.

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)